Christopher Allan

Christopher Allan is a Senior Scientist in Analytical Development at Curia (formerly AMRI) since October 2021. Previously, Christopher worked as a Senior Scientist at Biogelx Ltd. from June 2018 to September 2021, focusing on the development of biocompatible inks. Christopher completed a PhD in Chemical Biology at The University of Edinburgh under the supervision of Prof. Alison N from September 2014 to June 2018. Additionally, Christopher has experience as a Placement Student in Medicinal Chemistry at Almac Discovery and served as an Undergraduate Lab Demonstrator. Christopher holds an MSci degree in Chemistry with Medicinal Chemistry from the University of Glasgow, completed in 2014.